FDA

FDA

ORG Government / Drug and Device Regulation Momentum 64.3ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates pharmaceuticals, biologics, medical devices, and food safety covering ~20% of US consumer spending. In July 2026, approved novel diabetes and cancer immunotherapies, expanded OTC naloxone access, and launched PreCheck pilot with Eli Lilly and Fujifilm to streamline domestic drug manufacturing while flagging safety concerns around unregulated peptide compounding.

0.37

PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.

64.3

MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.

ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.

ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.

FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).

PSI Intelligence

30-Day Trend

Signal Decomposition

Attention Cascade

-0.500

Narrative Drift

0.116

Spectral Shift

533.141

Sentiment-Momentum Divergence

0.000

Source Concentration

0.752

Signal

FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).

Driver

Ranked #288 of 1193 in Government — in line with sector peers. PSI up 0.69 from yesterday (-0.32 -> 0.37).

Action

Baseline conditions. Continue standard monitoring cadence.

Peer Comparison

288 of 1193

Sector Rank

+0.51

Peer Z-Score

76%

Sector Percentile

Network Analysis

46 Degree Centrality

Ego Network (top connections)

Centrality History

Entity	Weight	Status
White House	50	STABLE
PlocamiumAI	45	NEW
United States	43	STABLE
HHS	36	STABLE
AstraZeneca	32	NEW
Dr.	28	NEW
Novo Nordisk	26	NEW
WASHINGTON	25	STABLE
Robert F. Kennedy Jr.	24	NEW
Eli Lilly	18	NEW
CMS	17	STABLE
China	17	STABLE
RFK Jr.	17	NEW
Americans	16	NEW
Europe	14	STABLE
President	12	STABLE
Reuters	11	STABLE
CEO	10	STABLE
AP	9	STABLE
U.S. Department of Health and Human Services	9	NEW
Canada	8	STABLE
Supreme Court	8	STABLE
Merck	8	STABLE
Senate	7	NEW
California	6	STABLE
Asia	6	STABLE
Donald Trump	6	STABLE
GOP	6	STABLE
CDC	6	STABLE
WSJ	6	NEW

Article Coverage (0)

Date	Lane	Title
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

FDA+ Note this entity

Request Access